EndoClot Plus announces FDA clearance of GI Submucosal lifting product
EndoClot SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Feb 20
EndoClot SIA is the first starch-derived submucosal injection system cleared in the U.S. market for endoscopic removal of…
19 Feb 20
SuperMap's user interface effortlessly guides electrophysiologists to quickly create exquisitely detailed whole-chamber maps of the left or right…
18 Feb 20
The CE Mark approval was based on data from two European clinical studies evaluating safety and efficacy of…
17 Feb 20
Venus Bliss device can be used for the non-invasive lipolysis of the abdomen and flanks
17 Feb 20
These recalled products were manufactured from October 2014 through June 2019
14 Feb 20
There is increasing pressure on the FDA to give members of the public improved access to details of…
14 Feb 20
The STIM onTrack technology works with the Orthofix Bone Growth Therapy devices. The mobile device app is an…
13 Feb 20
Q-NRG+ leverages indirect calorimetry (IC) technology, which is considered as gold standard for precise measurement of resting energy…
13 Feb 20
The expanded indication will enable Senhance system to treat paediatric patients above 10kg
12 Feb 20
The Surfacer System is intended to obtain central venous access to facilitate catheter insertion into the central venous…